Mirador Capital Partners’s Procept Biorobotics PRCT Stock Holding History

Mirador Capital Partners’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$356K	Hold	19,535	–	–	0.04%	178
2026 Q2	$441K	Buy	+19,535	New	+$489K	0.05%	165
2026 Q1	–	Sell	-7,480	Closed	-$235K	–	213
2025 Q4	$235K	Hold	7,480	–	–	0.03%	192
2025 Q3	$267K	Hold	7,480	–	–	0.04%	185
2025 Q2	$431K	Buy	+7,480	New	+$423K	0.07%	150

Other funds holding PRCT

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Mirador Capital Partners's PRCT Position: Q3 2026 in Review

Mirador Capital Partners held its Procept Biorobotics (PRCT) position steady in Q3 2026 at 19,535 shares worth $356K. The position accounts for 0.04% of the portfolio, ranked #178.

Mirador Capital Partners first reported a position in PRCT in Q2 2025 and has held it in 5 quarters since. The position peaked at $441K in Q2 2026. 7 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

Mirador Capital Partners held 19,535 shares of Procept Biorobotics worth $356K as of Q3 2026.
Mirador Capital Partners left its Procept Biorobotics share count unchanged in Q3 2026.
Procept Biorobotics made up 0.04% of Mirador Capital Partners's portfolio in Q3 2026, its #178 holding.
Mirador Capital Partners first reported a position in Procept Biorobotics in Q2 2025 and has held it in 5 quarters since.
Mirador Capital Partners's Procept Biorobotics position peaked at $441K in Q2 2026.
7 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Mirador Capital Partners's 13F filing for Q3 2026, filed 9 Oct 2026.